为确定皮质类固醇治疗对HELLP综合征的效果,尤其是不同剂量治疗对孕妇实验室值及孕龄的影响,对1995年3月～1999年7月间37例产前诊断为HELLP综合征(血小板<100 000/mm~3,天冬氨酸转移酶≥70 U/L,乳酸脱氢酶>600 U/L)的孕妇进行回顾性分析。将研究对象分3组,1组11例,未经皮质类固醇治疗;2组15例,为促胎肺成熟采用标准剂量皮质类固醇治疗,每12小时肌肉注射12 mg倍他米松共2次或每6小时静脉注射6 mg地塞米松共4次;3组 In order to determine the effect of corticosteroid therapy on HELLP syndrome, especially the effect of different doses on laboratory values ​​and gestational age of pregnant women, 37 prenatal diagnoses of HELLP syndrome (platelet) from March 1995 to July 1999 <100 000 / mm ~ 3, aspartate aminotransferase ≥ 70 U / L, lactate dehydrogenase> 600 U / L) were retrospectively analyzed. Subjects were divided into three groups, one group of 11 cases, no corticosteroid treatment; two groups of 15 cases, to promote fetal lung maturity standard dose corticosteroid therapy, intramuscular injection of 12 mg betamethasone a total of 12 times every 12 hours or 6 hours intravenous injection of 6 mg dexamethasone 4 times; 3 groups